Pathstone Family Office, LLC Aditxt, Inc. Transaction History

Pathstone Family Office, LLC

  • $15.6 Billion
  • Q3 2023

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 16, 2021
SELL
$1.89 - $2.48 $1,670 - $2,192
-884 Closed
0 $0
Q3 2020

Nov 12, 2020
BUY
$1.7 - $7.6 $1,502 - $6,718
884 New
884 $2,000

About Aditxt, Inc.

ADTX Quotes by TradingView
  • Ticker ADTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 4,161,130
  • Market Cap $541K
  • Description
  • Aditxt, Inc., a biotech company, develops technologies focuses on improving the health of the immune system through immune mapping and reprogramming. It develops AditxtScore that allows individuals to understand, manage, and monitor their immune profiles in order to be informed about attacks on or by their immune system; and Apoptotic DNA Immuno...
More about ADTX
Track This Portfolio

Track Pathstone Family Office, LLC Portfolio

Follow Pathstone Family Office, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pathstone Family Office, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pathstone Family Office, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email